SGLT-2 Inhibition and Cardiovascular Disease. Metabolomics Study of Potential Factors Involved in Cardioprotection - Trial 2017-005136-41
Access comprehensive clinical trial information for 2017-005136-41 through Pure Global AI's free database. This phase not specified trial is sponsored by Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina Y Salud (FIMABIS) and is currently Ongoing. The study focuses on Type 2 Diabetes mellitus.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina Y Salud (FIMABIS)
AstraZeneca
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
- Pregnancy (all women of child-bearing age, unless treatment with contraceptive methods, will undergo a pregnancy test)
ICD-10 Classifications
Data Source
EU Clinical Trials Register
2017-005136-41
Non-Device Trial